Please assess the completion status of the following clinical trial:

Trial Title: Role of Clinical Pharmacists in Epilepsy Management

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* were prescribed a monotherapy or polytherapy of phenytoin, carbamazepine, or valproic acid.~* were treated for more than one month.~Exclusion Criteria:~* were pregnant or breastfeeding women.~* had a history of alcoholism.~* had liver or renal disease.~* were using drugs known to have an influence on cytochrome P450 enzymes.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients with epilepsy (Type: EXPERIMENTAL): The therapies of patients with epilepsy were optimized using pharmacists' interventions, including medication consultation, dosage adjustment, medication switching/discontinuation, or combination therapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).